Kit Simpson to CD4-Positive T-Lymphocytes
This is a "connection" page, showing publications Kit Simpson has written about CD4-Positive T-Lymphocytes.
Connection Strength
0.086
-
Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya. Value Health. 2011 Dec; 14(8):1048-54.
Score: 0.086